Theseus Pharmaceuticals, Inc.
NASDAQ:THRX
4.065 (USD) • At close February 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 94.605 | 244.662 | 8.457 | 1.317 |
| Short Term Investments
| 103.374 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 197.979 | 244.662 | 8.457 | 1.317 |
| Net Receivables
| 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.137 | 3.309 | 0.113 | 0.064 |
| Total Current Assets
| 197.979 | 247.971 | 8.57 | 1.381 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 4.75 | 0.011 | 0.001 | 0.003 |
| Goodwill
| 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 |
| Long Term Investments
| 13.817 | 0.379 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 5.901 | 2.568 | 0.043 | 0.043 |
| Total Non-Current Assets
| 24.468 | 2.958 | 0.044 | 0.046 |
| Total Assets
| 222.447 | 250.929 | 8.614 | 1.427 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 4.973 | 1.002 | 1.132 | 0.285 |
| Short Term Debt
| 0.743 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 5.414 | 2.678 | 0.463 | 0.33 |
| Total Current Liabilities
| 11.13 | 3.68 | 1.595 | 0.615 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 3.236 | 0 | 0 | 0.002 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.466 | 0.815 | 0 | 10.217 |
| Total Non-Current Liabilities
| 3.702 | 0.815 | 41.289 | 10.219 |
| Total Liabilities
| 14.832 | 4.495 | 42.884 | 10.834 |
| Equity: | ||||
| Preferred Stock
| 0 | 250.929 | 41.289 | 6.857 |
| Common Stock
| 0.004 | 0.004 | 0 | 0 |
| Retained Earnings
| -112.186 | -61.578 | -34.27 | -10.22 |
| Accumulated Other Comprehensive Income/Loss
| -0.386 | -250.929 | 0 | 0.813 |
| Other Total Stockholders Equity
| 320.183 | 308.008 | -41.289 | -6.857 |
| Total Shareholders Equity
| 207.615 | 246.434 | -34.27 | -9.407 |
| Total Equity
| 207.615 | 246.434 | -34.27 | -9.407 |
| Total Liabilities & Shareholders Equity
| 222.447 | 250.929 | 8.614 | 1.427 |